RE:And away from politicsConfidence was not helped by the still-unexplained dosing debacle at the beginiing of Phase II and the speed with which the consequences were dumped on Shareholders.
May start to get some indicators on efficacy with the next Quarterly but as of now there is not a big enough sample from which to estimate the chance of someone being treated at the first of the 2 optimal doses achieving a CR.